Why a pet might need compounding

A dog may need a strength that is not commercially available. A cat may need a different dosage form. An animal may have an allergy to an inactive ingredient, or an unusual species may have no suitable approved product.

Those are individualized medical reasons—not a shortcut around drug approval or a reason to prefer compounded medication when an appropriate approved option is available.

Approved, extra-label, and compounded are different

FDA-approved drugs have been reviewed as finished products for safety, effectiveness, manufacturing quality, and labeling. Veterinarians may also use certain approved animal or human drugs extra-label under applicable law and a valid veterinarian-client-patient relationship.

Compounded animal drugs are not FDA-approved. When a bulk drug substance is used, FDA’s Guidance for Industry #256 describes limited circumstances in which the agency generally does not intend to take enforcement action. The clinical and legal details matter.

Questions to ask before filling the prescription

A trustworthy process should become clearer as you ask questions. Keep the product label and the pharmacy’s contact information, and report unexpected problems promptly.

  • Why does this individual pet need a compounded form?
  • Could an FDA-approved animal or human drug be used instead?
  • Is the prescription patient-specific, and who is the prescribing veterinarian?
  • Which licensed pharmacy will prepare it?
  • What are the concentration, route, storage conditions, and beyond-use date?
  • What benefit, side effects, laboratory work, and follow-up should we track?

Red flags

Be cautious when a site lets consumers choose an injectable drug from a menu, supplies disease-specific dosing without a veterinarian, hides the dispensing pharmacy, uses “research use only” as a treatment workaround, or describes compounding as FDA-approved.

The bottom line

Patient-specific means patient-specific.

Compounding is most defensible when the pet, medical need, prescriber, pharmacy, formulation, and monitoring plan are all identifiable.